CELLCOM ISRAEL LTD's ticker is CELJF and the CUSIP is M2196U109. A total of 42 filers reported holding CELLCOM ISRAEL LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $19,000 | -13.6% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $22,000 | +22.2% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | -92.2% | 3,200 | -90.1% | 0.00% | -85.7% |
| Q1 2018 | $230,000 | -39.8% | 32,410 | -12.5% | 0.01% | -36.4% |
| Q4 2017 | $382,000 | +10.4% | 37,050 | 0.0% | 0.01% | +10.0% |
| Q3 2017 | $346,000 | -2.8% | 37,050 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $356,000 | +1.1% | 37,050 | +9.1% | 0.01% | +11.1% |
| Q1 2017 | $352,000 | +39.7% | 33,950 | +8.8% | 0.01% | +28.6% |
| Q4 2016 | $252,000 | +39.2% | 31,200 | +28.9% | 0.01% | +40.0% |
| Q3 2016 | $181,000 | +72.4% | 24,200 | +54.1% | 0.01% | +66.7% |
| Q2 2016 | $105,000 | +61.5% | 15,700 | +72.5% | 0.00% | +50.0% |
| Q1 2016 | $65,000 | +14.0% | 9,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $57,000 | +18.8% | 9,100 | +19.7% | 0.00% | +100.0% |
| Q3 2015 | $48,000 | +50.0% | 7,600 | -5.0% | 0.00% | 0.0% |
| Q2 2015 | $32,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MEITAV INVESTMENT HOUSE LTD | 527,745 | $2,600,000 | 0.10% |
| Renaissance Technologies | 3,856,942 | $18,706,000 | 0.02% |
| Clal Insurance Enterprises Holdings Ltd | 197,526 | $895,000 | 0.01% |
| ARK Investment Management | 427,345 | $2,106,000 | 0.01% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 630,061 | $3,106,000 | 0.00% |
| Phoenix Holdings Ltd. | 20,840 | $101,000 | 0.00% |
| Qube Research & Technologies Ltd | 29,210 | $142,000 | 0.00% |
| CKW FINANCIAL GROUP | 1,000 | $5,000 | 0.00% |
| NORGES BANK | 889,375 | $4,385,000 | 0.00% |
| Swiss National Bank | 195,531 | $963,000 | 0.00% |